ICH Q9(R1)
Every DSRV article whose Regulatory Snapshot cites ICH Q9(R1): the enforcement case behind it, the inspection exposure it created, and what the desk would do about it.
- What has FDA cited under ICH Q9(R1)?
- 3 DSRV articles cite ICH Q9(R1). Enforcement cases behind them: Risk-proportionate control expectations under ICH Q9(R1) and pharmaceutical quality system principles in ICH Q10, applied to AI-assisted quality work; Data-integrity (ALCOA+) and quality risk management expectations under 21 CFR Parts 210/211 and ICH Q9(R1), applied to AI-generated inputs; ICH Q9(R1) Quality Risk Management (revised 2023); recurring FDA 483 cleaning-validation observations. Inspection exposure across them: 1 high, 1 moderate, 1 low.
- What does DSRV recommend for ICH Q9(R1)?
- From the newest article (Where AI Can Safely Support Pharma Quality Teams): AI belongs in preparation, pattern-surfacing, and pressure-testing - leverage for the quality team, with every regulated conclusion handed back to an accountable human. DSRV's matching service is the Quality Risk Management Tune-up, delivered through controlled intake at /submit. DSRV is decision support, not legal advice; verify against the official source each article names.
- 7 min readLow exposure
Where AI Can Safely Support Pharma Quality Teams
AI is most valuable in regulated quality work when it supports human judgment rather than replacing it. We map the tasks where AI adds real, low-risk leverage — and where the human must stay in control.
- Case
- Risk-proportionate control expectations under ICH Q9(R1) and pharmaceutical quality system principles in ICH Q10, applied to AI-assisted quality work.
- DSRV take
- AI belongs in preparation, pattern-surfacing, and pressure-testing - leverage for the quality team, with every regulated conclusion handed back to an accountable human.
- 7 min readModerate exposurecited as a tag
Why Generic AI Is Risky for Regulated Quality Decisions
General-purpose AI tools can sound authoritative while being wrong in ways that matter under GMP. We explain the specific failure modes — and what regulated quality work requires instead.
- Case
- Data-integrity (ALCOA+) and quality risk management expectations under 21 CFR Parts 210/211 and ICH Q9(R1), applied to AI-generated inputs.
- DSRV take
- Plausibility is not the GMP bar - an AI input that cannot show its sources, and may invent them, cannot underwrite a regulated decision.
- 11 min readHigh exposurecited as a tag
Risk-Based Cleaning Validation: Applying ICH Q9 Principles in Practice
Cleaning validation remains one of the most inspection-cited areas in pharmaceutical manufacturing. This article explores how a risk-based framework under ICH Q9 Rev.1 can rationalise your validation strategy.
- Case
- ICH Q9(R1) Quality Risk Management (revised 2023); recurring FDA 483 cleaning-validation observations.
- DSRV take
- A risk-based cleaning program is defensible only when worst-case selection and acceptance limits trace back to a documented risk assessment.
Quality Risk Management Tune-up
Bring the document that has to hold up under ICH Q9(R1). DSRV maps the evidence, names the gaps, and routes judgment calls to human review. Controlled intake, no public file upload.
Regulatory intelligence and interpretation, not legal advice. Verify against the official FDA or ICH source each article names.